Treatment With Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients With Ischemic Stroke Treated in Community Hospitals | Zendy

Shelby D. Reed | Zendy; Steven C. Cramer | Zendy; David K. Blough | Zendy; Kerry Meyer | Zendy; Jeffrey G. Jarvik | Zendy

Open Access

Treatment With Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients With Ischemic Stroke Treated in Community Hospitals

Author(s) -

Shelby D. Reed,

Steven C. Cramer,

David K. Blough,

Kerry Meyer,

Jeffrey G. Jarvik

Publication year - 2001

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/01.str.32.8.1832

Subject(s) - medicine , tissue plasminogen activator , stroke (engine) , odds ratio , retrospective cohort study , emergency medicine , surgery , mechanical engineering , engineering

Most analyses of intravenous tissue plasminogen activator (IV tPA) use for acute stroke in routine practice have been limited by sample size and generally restricted to patients treated in large academic medical facilities. In the present study, we sought to estimate among community hospitals the use of IV tPA and to identify factors associated with the use of IV tPA and inpatient mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research